Skip to content

CareDx CDNA Work in process

Work in process at other companies

QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$112.7M+22.1%
Abbott logo
AbbottABT
$994M+11.7%
Teladoc Health logo
Teladoc HealthTDOC
$1.1M+98.2%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's work in process?
CareDx (CDNA) reported work in process of $3.61M in Q1 2026.
How has CareDx's work in process changed year-over-year?
CareDx's work in process decreased by 24.9% year-over-year, from $4.81M to $3.61M.
What is the long-term trend for CareDx's work in process?
Over 5 years (2020 to 2025), CareDx's work in process has grown at a 5.0% compound annual growth rate (CAGR), from $2.94M to $3.74M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.